Medication Description: Ubinon (Ubinonum)
UBINON (Ubinonum). 6-Decaprenyl-2, 3-dimethoxy-5-methyl-1, 4-benzoquinone.
Synonyms: Coenzyme Q, Ko Q, Ubiquinone, Adelir, Coenzym Q, Emitolon, Inokiten, Parbinon, Sempinon, Senon, Terekol, Tridemin, Ubequinon, Ubidecarenone, Ubifactor, Ubirecanone, Ubiten, Udekinon and, Yubekonon, Ubifactor, Ubirecanone, Ubiten, Udekinon and, Yubekonon, Ubifactor, Ubirecanone, Ubiten, Udekinon and, Yubekonone, Ubifactor, Ubirecanone, Ubiten, Udekinon, and Yubekonone
Ubiquinone is a coenzyme widely distributed in the cells of the body. It is a carrier of hydrogen ions, a component of the respiratory chain. Chemically, it is a benzoquinone derivative.
For medical use get synthetically.
As a drug, it is used as an antioxidant that can inhibit lipid peroxidation (see Tocopherol acetate, Dibunol) and have an antihypoxic effect.
The main use is in the treatment of patients with coronary heart disease, with myocardial infarction. It is noted that the use of the drug improves the clinical course of the disease, increases exercise tolerance, increases the blood levels of prostacyclin and decreases the content of thromboxane. Ubinin is also prescribed to athletes for recovery.
Assign adults inside (regardless of the meal time) for medicinal purposes, 0.03 g (2 capsules) 3 times a day. The course of treatment 1 - 3 months. Athletes are prescribed 0.045 g 2 - 3 times a day for 7 - 10 days.
The drug is usually well tolerated. In some cases, possible nausea, disorders of the chair; then the drug is stopped.
Form release: in capsules of 0,015 g in the form of a solution in oil.
Storage: in a dry, dark place at room temperature.